These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6705149)

  • 21. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis.
    Jung EG
    Bull Cancer; 1978; 65(3):315-21. PubMed ID: 719183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xeroderma pigmentosum with multiple malignancies.
    Nalgirkar AR; Borkar SS; Nalgirkar SA
    Indian Pediatr; 2000 Dec; 37(12):1377-9. PubMed ID: 11119344
    [No Abstract]   [Full Text] [Related]  

  • 26. Xeroderma Pigmentosum - Facts and Perspectives.
    Lehmann J; Seebode C; Martens MC; Emmert S
    Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Pegylated Interferon and Mitomycin C on Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum: A Case Series.
    Dirar QS; Musalem HM; Al-Hazzaa SAF; Al Zoba AA; Almalki AA
    Am J Case Rep; 2020 Apr; 21():e921301. PubMed ID: 32251268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
    Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
    Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review.
    Baskurt D; Vural S; Ertekin SS; Baykal C
    Int J Dermatol; 2024 Jan; 63(1):59-72. PubMed ID: 37964400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xeroderma pigmentosum clinical practice guidelines.
    Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
    J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shining a light on xeroderma pigmentosum.
    DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.
    Kraemer KH; DiGiovanna JJ
    Photochem Photobiol; 2015; 91(2):452-9. PubMed ID: 25220021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum and the role of DNA repair in oncogenesis.
    Giannelli F
    Bull Cancer; 1978; 65(3):323-34. PubMed ID: 719184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xeroderma pigmentosum in the United kingdom.
    Lehmann AR
    Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xeroderma pigmentosum: review and report of a case.
    Patton LL; Valdez IH
    Oral Surg Oral Med Oral Pathol; 1991 Mar; 71(3):297-300. PubMed ID: 2011352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total-body cutaneous examination, total-body photography, and dermoscopy in the care of a patient with xeroderma pigmentosum and multiple melanomas.
    Green WH; Wang SQ; Cognetta AB
    Arch Dermatol; 2009 Aug; 145(8):910-5. PubMed ID: 19687422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoma of the tongue in xeroderma pigmentosum].
    Huet-Lamy P; Dereure O; Degavre B; Atlan PY; Guillot B; Guilhou JJ
    Ann Dermatol Venereol; 1992; 119(12):980-2. PubMed ID: 1304692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.